Celltrion
068270.KS
#799
Rank
โ‚ฌ28.14 B
Marketcap
122,73ย โ‚ฌ
Share price
-0.50%
Change (1 day)
15.24%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: โ‚ฌ28.14 Billion

As of August 2026 Celltrion has a market cap of โ‚ฌ28.14 Billion. This makes Celltrion the world's 799th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ28.14 B21.15%
2025โ‚ฌ23.23 B-8.39%
2024โ‚ฌ25.35 B-16.27%
2023โ‚ฌ30.28 B79.19%
2022โ‚ฌ16.90 B-17.45%
2021โ‚ฌ20.47 B-44.15%
2020โ‚ฌ36.65 B106.25%
2019โ‚ฌ17.77 B-18.13%
2018โ‚ฌ21.70 B1.2%
2017โ‚ฌ21.45 B107.57%
2016โ‚ฌ10.33 B39.82%
2015โ‚ฌ7.39 B148.23%
2014โ‚ฌ2.97 B15.29%
2013โ‚ฌ2.58 B-21.37%
2012โ‚ฌ3.28 B16.83%
2011โ‚ฌ2.81 B8.49%
2010โ‚ฌ2.59 B181.57%
2009โ‚ฌ0.92 B59.55%
2008โ‚ฌ0.57 B4409.11%
2007โ‚ฌ12.79 M